Computer-Assisted HIV Prevention for Young Drug Users

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2008 by National Development and Research Institutes, Inc..
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Daytop (adolescent treament program)
St. Luke's-Roosevelt Hospital Center
Information provided by:
National Development and Research Institutes, Inc.
ClinicalTrials.gov Identifier:
NCT00182585
First received: September 10, 2005
Last updated: August 11, 2008
Last verified: August 2008

September 10, 2005
August 11, 2008
August 2004
Not Provided
HIV risk behavior
Same as current
Complete list of historical versions of study NCT00182585 on ClinicalTrials.gov Archive Site
  • knowledge related to HIV, Hepatitis, STDs
  • behavioral intentions
  • attitudes toward risk-reduction behavior
  • feedback on intervention
Same as current
Not Provided
Not Provided
 
Computer-Assisted HIV Prevention for Young Drug Users
Computer-Assisted HIV Prevention for Young Drug Users

In this study, the investigators are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies.

Adolescents and young adults who use drugs are at high risk for infection with HIV, STDs and other diseases with similar transmission dynamics. Although several age-appropriate and effective HIV, STD and disease prevention efforts have been identified for young substance abusers, most interventions have been narrow in focus and are generally not structured to readily address changing patterns of drug use among adolescents that place them at risk for infection with these diseases. In this study, we are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies. We plan to develop this program with the input from the target population of adolescents and young adults. We also plan to conduct a randomized, controlled trial to evaluate the benefit of including this program in HIV and disease prevention efforts with youth in substance abuse treatment. In so doing, we will evaluate the ability of the program to promote accurate knowledge about HIV and other diseases, promote self-efficacy to reduce risk behavior and change actual rates of risk behavior among young substance abusers. This computer-based program will be designed to promote the increased adoption of effective HIV and disease prevention science for this population. New information about changing patterns of drug use and HIV risk behaviors can be readily incorporated into the program as it becomes available. The program can be easily exported and able to be applied with fidelity. Importantly, the program will be structured such that a therapist or educator may customize the program content for use by various sub-populations of substance-abusing adolescents and young adults. Thus, the program will be able to address risk factors specific to each young drug user. This program may address many of the challenges associated with the current delivery of evidence-based HIV prevention programs to this population.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
HIV
  • Procedure: computer-based HIV, STD & Hepatitis Education
  • Procedure: educator-delivered HIV, STD and Hepatitis education
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
56
Not Provided
Not Provided

Inclusion Criteria:

  • Aadolescents in outpatients substance abuse treatment
  • Ages 13 - 18 years
  • Within first month of treatment entry

Exclusion Criteria:

Both
13 Years to 18 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00182585
R01 DA015964
Not Provided
Not Provided
National Development and Research Institutes, Inc.
  • Daytop (adolescent treament program)
  • St. Luke's-Roosevelt Hospital Center
Principal Investigator: Lisa Marsch, PhD National Development and Research Institutes, Inc.
National Development and Research Institutes, Inc.
August 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP